Carl Stubbings is the Commercialisation Lead for Minomic International Limited. Carl is a highly qualified senior executive with over thirty years’ of global experience in the biotechnology and medical diagnostic industries. With expertise across the manufacturing, administration, sales & marketing areas Carl has worked across the industry to successfully commercialise products to the market. In his role at Panbio (USA) and Focus Diagnostics, Carl led the commercialisation of number of medical diagnostic products which included the first FDA cleared test for West Nile Virus and the first FDA cleared molecular test for H1N1. Carl has successfully leveraged this experience to benefit the Australian biotechnology ecosystem.